Document Detail

Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis.
MedLine Citation:
PMID:  7670536     Owner:  NLM     Status:  MEDLINE    
The purpose of this study was to evaluate serum levels of TNF-alpha in patients with either of the three clinical forms of American cutaneous leishmaniasis. The 86 patients examined were classified as having either the localized (LCL: 22 patients), mucocutaneous (MCL: 45 patients), or the rare diffuse (DCL: 19 patients) form of the disease. Our results show a significant increase in the mean level of TNF-alpha in the three groups of patients when compared to controls. MCL patients produce significantly higher levels of TNF-alpha than DCL patients. The proportion of individuals positive for serum TNF-alpha was significantly higher in both MCL and DCL patients than in the controls. No significant differences were found in the level of TNF-alpha when compared between before and after cure of 12 patients with MCL. There were no significant correlations between the level of TNF-alpha and the skin test diameter. The results will be discussed in terms of the pathogenesis of the disease in its different clinical forms.
M Castes; D Trujillo; M E Rojas; C T Fernandez; L Araya; M Cabrera; J Blackwell; J Convit
Related Documents :
7661926 - Circulating interleukin-6 receptor in patients with sepsis syndrome.
8653926 - Interleukin-6 and soluble interleukin-6 receptor in peritoneal fluid and serum of patie...
12090356 - Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infa...
11112466 - Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors an...
7062746 - Primary cardiac tumors: experience with 25 cases.
20086296 - Pcr-based clonality assessment in patients with lymphocytic leukaemias: a single-instit...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biological research     Volume:  26     ISSN:  0716-9760     ISO Abbreviation:  Biol. Res.     Publication Date:  1993  
Date Detail:
Created Date:  1995-10-19     Completed Date:  1995-10-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9308271     Medline TA:  Biol Res     Country:  CHILE    
Other Details:
Languages:  eng     Pagination:  233-8     Citation Subset:  IM    
Instituto de Biomedicina, Escuela J.M. Vargas, Facultad de Medicina, Universidad Central de Venezuela, Caracas.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, Protozoan / immunology
Hypersensitivity, Delayed / immunology
Leishmania / immunology
Leishmaniasis, Cutaneous / blood*
Leishmaniasis, Diffuse Cutaneous / blood
Leishmaniasis, Mucocutaneous / blood
Middle Aged
Tumor Necrosis Factor-alpha / analysis*,  metabolism
Reg. No./Substance:
0/Antigens, Protozoan; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cell mediated immune response in patients with Chagas. Correlation with the presence of Chagasic car...
Next Document:  cAMP receptor protein from Trypanosoma cruzi: purification and cloning of a short sequence of the co...